James N Topper is Chief Executive Officer of Frazier Lifesciences Acquisition Corp. Currently has a direct ownership of 1 Million shares of FLAC, which is worth approximately $0. The most recent transaction as insider was on Dec 11, 2020, when has been sold 1,000,000 shares (Class A Ordinary Shares) at a price of $10.0 per share, resulting in proceeds of $10,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1M
0% 3M change
0% 12M change
Total Value Held $0

James N Topper Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2020
BUY
Open market or private purchase
$10,000,000 $10.0 p/Share
1,000,000 Added 50.0%
1,000,000 Class A Ordinary Shares
Dec 11 2020
BUY
Grant, award, or other acquisition
$5,010,000 $10.0 p/Share
501,000 Added 50.0%
501,000 Class A Ordinary Shares

Also insider at

ANAB
ANAPTYSBIO, INC Healthcare
ALNA
Allena Pharmaceuticals, Inc. Healthcare
ALPN
ALPINE IMMUNE SCIENCES, INC. Healthcare
PHAT
Phathom Pharmaceuticals, Inc. Healthcare
NAMS
NewAmsterdam Pharma Co N.V.
JNT

James N Topper

Chief Executive Officer
Florham Park,, NJ

Track Institutional and Insider Activities on FLAC

Follow Frazier Lifesciences Acquisition Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FLAC shares.

Notify only if

Insider Trading

Get notified when an Frazier Lifesciences Acquisition Corp insider buys or sells FLAC shares.

Notify only if

News

Receive news related to Frazier Lifesciences Acquisition Corp

Track Activities on FLAC